Company Filing History:
Years Active: 1998
Title: Bo Syennerholm: Innovator in Vaccine Development
Introduction
Bo Syennerholm is a notable inventor based in Goteborg, Sweden. He has made significant contributions to the field of vaccine development, particularly in the fight against HIV. His innovative work focuses on the creation of peptides that can enhance immune responses.
Latest Patents
Bo Syennerholm holds a patent for "Peptides for use in vaccination and induction of neutralizing antibodies." This patent discloses novel peptides that correspond to epitopes of the HIV-1 gp120 protein. These antigenic peptides are designed to induce antibody-dependent cellular cytotoxicity against HIV, making them valuable for immunization against HIV infection and for enhancing the immune response to the virus.
Career Highlights
Throughout his career, Bo has been dedicated to advancing vaccine technology. His work at Syntello Vaccine Development Kb has positioned him as a key player in the development of innovative solutions for infectious diseases. His research has the potential to significantly impact public health by providing new avenues for HIV prevention.
Collaborations
Bo Syennerholm has collaborated with esteemed colleagues such as Anders Vahlne and Lars Rymo. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Bo Syennerholm's contributions to vaccine development, particularly in the context of HIV, highlight his role as an important inventor in the field. His innovative peptides represent a promising advancement in immunization strategies.